Genomics and NHL Therapies

Genomics and NHL Therapies

Genomics medicine is likely to play an increasingly important role in the development of targeted as well as personalised therapies…

More...
DLBCL: Survival Determinants

DLBCL: Survival Determinants

Where a person lives at the time of being diagnosed with diffuse large B-cell lymphoma has a positive effect on…

More...
DLBCL and 24-month EFS

DLBCL and 24-month EFS

Patients with diffuse large B-cell lymphoma (DLBCL) who achieve event-free survival at 24 months also have overall survival that is…

More...
Undertreatment of Neutropenia

Undertreatment of Neutropenia

Patients younger than 65 years who have non-Hodgkin lymphoma (NHL) are less likely to receive prophylactic treatment for grade 3…

More...
Frontpage Slideshow | Copyright © 2006-2011 JoomlaWorks Ltd.

Healthcare Matters

  • 1
  • 2
  • 3
Prev Next

State of Healthcare in India

India is a country of more than 1.2 billion people comprising 28 states and seven union territories. There are 14 official languages in addition to Hindi and English, and within those languages numerous dialects. Consequently, it’s not surprising that India’s healthcare system is somewhat reflective of these differences: each state and union territory has its own healthcare system with its own healthcare priorities and medical schemes.

Read more

A Peek at Lymphoma Association UK

Numerous ways to keep both those with lymphomas informed as well as the lymphoma community engaged are used by the Lymphoma Association in the UK. Heading up a team of seven, Pierre du Bois, Head of Information and Communications, is responsible for the communication needs of the association.

Read more

State of Healthcare in Brazil

Brazil is projected to become the world’s sixth largest pharmaceutical market by 2014 which should, in theory, provide an excellent market for new and innovative therapies for patients with lymphoma and leukaemia. Adding to the potential attractiveness of the Brazilian market is that universal access to healthcare is guaranteed for all citizens, regardless of income and whether or not the person is Brazilian.

Read more

Latest Lymphoma News

  • New Treatment for CLL in USA

    Patients living in the USA who have chronic lymphocytic leukaemia (CLL) now have a new treatment option with the approval of ibrutinib (Imbruvica). The Food and Drug Administration approved the use of ibrutinib in patients


    Read more...
  • Non-Hodgkin Lymphoma Q&A

    In this video question-and-answer session, Dr. Steven Horwitz, a medical oncologist at Memorial Sloan Kettering Cancer Center, answers questions about different types of lymphomas


    Read more...

What's Happening Around the World

  • A Peek at France Lymphome Espoir

    Until recently, France Lymphome Espoir (FLE) has relied heavily on volunteers as well its president, Guy Bouguet, to get things done.

    “When you are a growing organisation, it means you have to do almost everything and anything,” said Guy.

    Read more...  
  • 2013 Social Entrepreneur Award Winner

    Brazil’s Merula Steagall of ABRALE and ABRASTA Wins Prestigious Award - Congratulations to Merula Steagall, one of LC’s outstanding members, for winning Latin America’s 2013 Social Entrepreneur Award.

    Read more...  

Research

  • Idelalisib and iNHL

    In a phase II study, patients with indolent non-Hodgkin lymphoma who had not responded to conventional therapy or had relapsed within six months of receiving therapy appeared to have a favourable response to idelalisib.

    Read more...  
  • HL and Breast Cancer

    Adolescent girls treated for Hodgkin lymphoma (HL) are at considerable risk of developing breast cancer, based on results from an observational study. This study was undertaken in Germany and was based on long-term observation of 590 female patients from German-Austrian paediatric clinical trials undertaken between 1978 and 1995.

    Read more...  

 
The information on this website is for general use only. Please consult your physician if you think you may have lymphoma or require more detailed information on the best course of treatment for you.

IN THE NODE

Updates

  • Follicular Lymphoma: Previously Treated

    A webcast examining the issues in those with follicular lymphoma who’ve previously been treated. Webcast courtesy of the Lymphoma Research Foundation (LRF). For more information, visit www.lymphoma.org.

  • Great Scholarship Opportunity

    Scholarships are available for patient advocates to attend the 2014 ASCO Annual Meeting.

  • Linfoma: Avances en la investigación

    Linfoma: Avances en la investigación | Semana Internacional de las Enfermedades Oncohematológicas 2013

  • Bendamustine Use in HL

    Following stem cell transplant failure in Hodgkin lymphoma bendamustine is an effective treatment.

  • Benefits of Physical Activity

    Being active can improve cancer survival odds.

asd